These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11814785)

  • 21. Total synthesis of ezetimibe, a cholesterol absorption inhibitor.
    Śnieżek M; Stecko S; Panfil I; Furman B; Chmielewski M
    J Org Chem; 2013 Jul; 78(14):7048-57. PubMed ID: 23763523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Jan; 8(1):35-40. PubMed ID: 9871624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Azetidinones as inhibitors of cholesterol absorption.
    Burnett DA; Caplen MA; Davis HR; Burrier RE; Clader JW
    J Med Chem; 1994 Jun; 37(12):1733-6. PubMed ID: 8021912
    [No Abstract]   [Full Text] [Related]  

  • 24. An enzymatic synthesis of glucuronides of azetidinone-based cholesterol absorption inhibitors.
    Reiss P; Burnett DA; Zaks A
    Bioorg Med Chem; 1999 Oct; 7(10):2199-202. PubMed ID: 10579526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
    Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
    Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.
    Altmann SW; Davis HR; Yao X; Laverty M; Compton DS; Zhu LJ; Crona JH; Caplen MA; Hoos LM; Tetzloff G; Priestley T; Burnett DA; Strader CD; Graziano MP
    Biochim Biophys Acta; 2002 Jan; 1580(1):77-93. PubMed ID: 11923102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-lactam cholesterol absorption inhibitors.
    Burnett DA
    Curr Med Chem; 2004 Jul; 11(14):1873-87. PubMed ID: 15279572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors.
    Yuan X; Lu P; Xue X; Qin H; Fan C; Wang Y; Zhang Q
    Bioorg Med Chem Lett; 2016 Feb; 26(3):849-853. PubMed ID: 26783178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabbit small intestine does not contain an annexin II/caveolin 1 complex as a target for 2-azetidinone cholesterol absorption inhibitors.
    Kramer W; Corsiero D; Girbig F; Jähne G
    Biochim Biophys Acta; 2006 Jan; 1758(1):45-54. PubMed ID: 16458850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
    Clader JW; Burnett DA; Caplen MA; Domalski MS; Dugar S; Vaccaro W; Sher R; Browne ME; Zhao H; Burrier RE; Salisbury B; Davis HR
    J Med Chem; 1996 Sep; 39(19):3684-93. PubMed ID: 8809157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 35. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane.
    Kramer W; Girbig F; Corsiero D; Pfenninger A; Frick W; Jähne G; Rhein M; Wendler W; Lottspeich F; Hochleitner EO; Orsó E; Schmitz G
    J Biol Chem; 2005 Jan; 280(2):1306-20. PubMed ID: 15494415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
    Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
    Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezetimibe. Schering-Plough.
    Meng CQ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):427-32. PubMed ID: 12054091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapies targeting exogenous cholesterol uptake: new insights and controversies.
    Davidson MH
    Curr Atheroscler Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21188557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
    Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K
    Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.